Search Results
Search for other papers by Dulani Kottahachchi in
Google Scholar
PubMed
Department of Medicine, Monash University, Melbourne, VIC, Australia
Search for other papers by Duncan J. Topliss in
Google Scholar
PubMed
Introduction Immunoglobulin G4-related disease (IgG4-RD) is a new clinical disease entity which is characterized by a dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells in the affected tissues, with a tendency to form
Search for other papers by Christophe Ghys in
Google Scholar
PubMed
Search for other papers by Michel Depierreux in
Google Scholar
PubMed
Search for other papers by Elçin Ozalp in
Google Scholar
PubMed
Search for other papers by Brigitte Velkeniers in
Google Scholar
PubMed
What Is Known about This Topic? • Immunoglobulin G4-related disease (IgG4-RD) is a newly recognized fibroinflammatory process defined by a dense lymphoplasmacytic infiltrate rich in IgG4. Riedel's thyroiditis and a subclass of sclerosing
Search for other papers by Asena Gökçay Canpolat in
Google Scholar
PubMed
Search for other papers by Murat Cinel in
Google Scholar
PubMed
Search for other papers by Serpil Dizbay Sak in
Google Scholar
PubMed
Search for other papers by Işılay Taşkaldıran in
Google Scholar
PubMed
Search for other papers by Hakan Korkmaz in
Google Scholar
PubMed
Search for other papers by Özgür Demir in
Google Scholar
PubMed
Search for other papers by Reyhan Ersoy in
Google Scholar
PubMed
Search for other papers by Selçuk Dağdelen in
Google Scholar
PubMed
Search for other papers by Dilek Berker in
Google Scholar
PubMed
Search for other papers by Klara Dalva in
Google Scholar
PubMed
Search for other papers by Adile Begüm Bahçecioğlu Mutlu in
Google Scholar
PubMed
Search for other papers by Murat Faik Erdoğan in
Google Scholar
PubMed
Introduction Immunoglobulin G4-related disease (IgG4-RD) is characterized by an immune-mediated fibroinflammatory process that can affect various organs [ 1 ]. Riedel thyroiditis (RT) is a rare form of thyroiditis, which may also occur as part
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
Search for other papers by Kenneth Ka Hei Lai in
Google Scholar
PubMed
Department of Ophthalmology, Salmaniya Medical Complex, Government Hospitals, Bahrain
Search for other papers by Fatema Mohamed Ali Abdulla Aljufairi in
Google Scholar
PubMed
Department of Ophthalmology, Vicente Sotto Memorial Medical Center, Cebu City, Philippines
Search for other papers by Jake Uy Sebastian in
Google Scholar
PubMed
Search for other papers by Yingying Wei in
Google Scholar
PubMed
Search for other papers by Ruofan Jia in
Google Scholar
PubMed
Search for other papers by Karen Kar Wun Chan in
Google Scholar
PubMed
Search for other papers by Elaine Yuen Ling Au in
Google Scholar
PubMed
Search for other papers by Alan Chun Hong Lee in
Google Scholar
PubMed
Search for other papers by Chiu Ming Ng in
Google Scholar
PubMed
Hong Kong Eye Hospital, Hong Kong Special Administrative Region, China
Search for other papers by Hunter Kwok Lai Yuen in
Google Scholar
PubMed
Search for other papers by Wilson Wai Kuen Yip in
Google Scholar
PubMed
Search for other papers by Alvin Lerrmann Young in
Google Scholar
PubMed
Search for other papers by George Pak Man Cheng in
Google Scholar
PubMed
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
Hong Kong Eye Hospital, Hong Kong Special Administrative Region, China
Search for other papers by Clement Chee Yung Tham in
Google Scholar
PubMed
Search for other papers by Chi Pui Pang in
Google Scholar
PubMed
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
Hong Kong Eye Hospital, Hong Kong Special Administrative Region, China
Search for other papers by Kelvin Kam Lung Chong in
Google Scholar
PubMed
inhibitor immunoglobulin (TBII) assay is the conventional method, and it does not differentiate between the TRAbs subtypes ( 10 ). TBII level is closely related to Graves’ disease; however, the relationship with TED is inconsistent ( 11 , 12 , 13
Search for other papers by Liyuan Liu in
Google Scholar
PubMed
Search for other papers by Yang Yu in
Google Scholar
PubMed
Search for other papers by Lei Chen in
Google Scholar
PubMed
Search for other papers by Yang Zhang in
Google Scholar
PubMed
Search for other papers by Guizhi Lu in
Google Scholar
PubMed
Search for other papers by Ying Gao in
Google Scholar
PubMed
Search for other papers by Junqing Zhang in
Google Scholar
PubMed
Yoshino T Kloppel G Heathcote JG Khosroshahi A Ferry JA Consensus statement on the pathology of IgG4-related disease . Modern Pathology 2012 25 1181 – 1192 . ( https://doi.org/10.1038/modpathol.2012.72 ) 17 Yu Y Gao Y . Progress in
Search for other papers by Zohar Steinberg Ben-Zeev in
Google Scholar
PubMed
Search for other papers by Marina Peniakov in
Google Scholar
PubMed
Search for other papers by Clari Felszer in
Google Scholar
PubMed
Search for other papers by Scott A Weiner in
Google Scholar
PubMed
Search for other papers by Avishay Lahad in
Google Scholar
PubMed
Search for other papers by Shlomo Almashanu in
Google Scholar
PubMed
The Rappaport Faculty of Medicine, Technion, Institute of Technology, Haifa, Israel
Search for other papers by Yardena Tenenbaum Rakover in
Google Scholar
PubMed
Introduction Maternal thyroid diseases are considered a risk factor for abnormal thyroid function at birth ( 1 , 2 , 3 , 4 , 5 ), as well as for long-term morbidity in offspring ( 1 , 6 , 7 , 8 , 9 , 10 , 11 ). Maternal
Search for other papers by Earn H. Gan in
Google Scholar
PubMed
Search for other papers by Anna L. Mitchell in
Google Scholar
PubMed
Search for other papers by Ruth Plummer in
Google Scholar
PubMed
Search for other papers by Simon Pearce in
Google Scholar
PubMed
Search for other papers by Petros Perros in
Google Scholar
PubMed
in this disease [ 4 , 5 ]. However, immune-related adverse events, including endocrinopathies, are common with these therapies [ 6 , 7 ]. Hypophysitis is among the most common dose-dependent endocrine adverse event in anti-CTLA-4 therapies, followed
Search for other papers by Yuan Li in
Google Scholar
PubMed
Department of Endocrinology, The First Hospital of Hebei Medical University, Shijiazhuang, China
Search for other papers by Chenxu Zhao in
Google Scholar
PubMed
College of Life Science, University of the Chinese Academy of Sciences, Beijing, China
Search for other papers by Keli Zhao in
Google Scholar
PubMed
Search for other papers by Nan Yu in
Google Scholar
PubMed
College of Life Science, University of the Chinese Academy of Sciences, Beijing, China
Search for other papers by Yan Li in
Google Scholar
PubMed
Search for other papers by Yang Yu in
Google Scholar
PubMed
Search for other papers by Yang Zhang in
Google Scholar
PubMed
College of Life Science, University of the Chinese Academy of Sciences, Beijing, China
Search for other papers by Zhijing Song in
Google Scholar
PubMed
Search for other papers by Youyuan Huang in
Google Scholar
PubMed
Search for other papers by Guizhi Lu in
Google Scholar
PubMed
Search for other papers by Ying Gao in
Google Scholar
PubMed
Search for other papers by Junqing Zhang in
Google Scholar
PubMed
Search for other papers by Xiaohui Guo in
Google Scholar
PubMed
IgG4 was detected. AAL, Aleuria aurantia lectin; ConA, concanavalin A lectin; CON, healthy controls; GD, Graves’ disease; HT, Hashimoto’s thyroiditis; IgG, immunoglobulin G; IRA, Iris hybrid lectin (Dutch iris); LCA, Lens culinaris agglutinin
Search for other papers by Tanja Diana in
Google Scholar
PubMed
Search for other papers by Hans-Peter Holthoff in
Google Scholar
PubMed
Search for other papers by Julia Fassbender in
Google Scholar
PubMed
Search for other papers by Christian Wüster in
Google Scholar
PubMed
Search for other papers by Michael Kanitz in
Google Scholar
PubMed
Search for other papers by George J. Kahaly in
Google Scholar
PubMed
Search for other papers by Martin Ungerer in
Google Scholar
PubMed
TBAb) profile, levels of TSHR-binding inhibitory immunoglobulins (TBII) and free thyroxine (fT4) serum levels were measured and evaluated in a novel, long-term murine model for human GD using 7 repeated immunizations over 27 weeks with Ad-TSHR. These
Search for other papers by Tanja Diana in
Google Scholar
PubMed
Search for other papers by Paul D. Olivo in
Google Scholar
PubMed
Search for other papers by Yie-Hwa Chang in
Google Scholar
PubMed
Search for other papers by Christian Wüster in
Google Scholar
PubMed
Search for other papers by Michael Kanitz in
Google Scholar
PubMed
Search for other papers by George J. Kahaly in
Google Scholar
PubMed
adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves’ disease . J Clin Endocrinol Metab . 1976 Feb ; 42 ( 2 ): 341 – 54 . 10.1210/jcem-42-2-341 946604 0021-972X 22 Macchia E , Carayon P , Fenzi GF